Financials
- Market Capitalization 297.83 M
- Employee 5
- Founded 2021
- CEO Jeffrey A. Meckler
- Website www.indaptusrx.com
- Headquarter Delaware, United States
- FIGI BBG00ZNLVBC8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.13
市销率
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3340 | GALT Galectin Therapeutics Inc. - Common Stock | 4.60 USD | +13.30% | 0.00% | +71.64% | +56.46% | 302.94 M USD | ||
| 3354 | ELDN Eledon Pharmaceuticals, Inc. - Common Stock | 3.86 USD | +0.26% | -3.26% | +6.93% | -5.16% | 297.94 M USD | ||
| 3360 | NMRA Neumora Therapeutics, Inc. - Common Stock | 1.60 USD | -4.76% | -4.19% | +72.04% | +24.03% | 296.45 M USD | ||
| 3386 | MGNX MacroGenics, Inc. - Common Stock | 4.50 USD | +3.93% | -2.17% | +13.64% | +186.62% | 286.03 M USD |